In contrast, Roca et al. reported that the anti-angiogenic cytokine plasminogen activator inhibitor-1 (PAI-1) is upregulated after HT and that its anti-angiogenic activities lessen tumor regrowth after HT treatment [266]. This evidence concerns the gene SERPINE1 and neoplasm.